Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
MRK News
Truist downgraded Verona Pharma (VRNA) to Hold from Buy with a price target of $107, up from $100, following Merck’s (MRK) $10B proposal to acquire all Verona f...
Analyst Tim Anderson from Bank of America Securities reiterated a Buy rating on Merck & Company and keeping the price target at $99.00. Don’t Miss TipRanks’ Ha...
Merck & Co. Inc. MRK agreed on Wednesday to acquire Verona Pharma plc VRNA for $107 per American Depository Share (ADS) for a total transaction value of approxi...
Analyst ratings
64%
of 25 ratingsMore MRK News
Update: Adds deal confirmation Merck (NYSE:MRK) has confirmed a deal worth around $10 billion to acquire Verona Pharma (NASDAQ:VRNA), a biotech firm specializi...
06:31 EDT Merck (MRK) to acquire Verona Pharma (VRNA) for $107.00 per ADS Published first on TheFly – the ultimate source for real-time, market-moving breaking...
Merck (MRK) is close to a deal to buy lung disease-focused biotech Verona Pharma (VRNA) for roughly $10B, The Financial Times’ Oliver Barnes reports. An acquisi...
recently announced updates on its HIV research, which are set to be unveiled at the upcoming International AIDS Society Conference. This announcement, coupled w...
